NCT07226206: A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 5 planned
- Started
- 8 Sep 2026
- Primary completion
- 30 Apr 2032
- Arms
- SPK-8011QQ
- Results
- None posted
- 10 Nov 2025: Trial registered
- 8 Sep 2026: Trial started